Results

Total Results: 513 records

Showing results for "diabetic".
Users also searched for: diabetes

41. Screening for Type 2 Diabetes Mellitus in Adults: U.S. Preventive Services Task Force Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/MtCxSYE8eYd2EzUGV8cMzH
    Screening for Type 2 Diabetes Mellitus in Adults: U.S. Preventive Services Task Force Recommendation Statement Figure. Screening for type 2 diabetes mellitus in adults: clinical summary of a U.S. Preventive Services Task Force (USPSTF) recommendation statement. Screening for Type 2 Diabetes Mellitus in Adults Clinic…

42. Screening for Prediabetes and Type 2 Diabetes: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/h8qcZeQ68AQPS9DemArgXX
    July 13, 2021 - Screening for Prediabetes and Type 2 Diabetes: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force (Reprinted) Clinical Review & Education JAMA | US Preventive Services Task Force | EVIDENCE REPORT Screening for Prediabetes and Type 2 Diabetes Updated Evidence Report and Syst…

43. Archived: Published Comment and Response: Do Lipid-Lowering Agents Provide a Greater Reduction in Cardiovascular Events among Patients with Diabetes?: Diabetes Mellitus (Type 2) in Adults: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/published-comment-and-response-do-lipid-lowering-agents-provide-a-greater-reduction-in-cardiovascular-events-among-patients-with-diabetes/diabetes-mellitus-type-2-in-adults-screening-2008
    November 15, 2008 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Published Comment and Response: Do Lipid-Lowering Agents Provide a Greater Reduction in Cardiovascular Events among Patients with Diabetes? Diabetes Mellitus (Type 2) in…

44. Tjdzc7Rzm3Wzcdhfc4Sjhq (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/TjDzC7rzm3WzCDHFC4sJhQ
    June 01, 2015 - Randomized controlled trial of reinforced healthy-living advice in subjects with increased but not diabetic … Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, … Control: Health/diabetic education once a month (n=86) Patients with IGT and BMI >19 A vs.

45. Archived: Screening: Evidence Summary: Gestational Diabetes Mellitus, Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/-screening-evidence-summary/gestational-diabetes-mellitus-screening-january-2014
    May 15, 2013 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Screening: Evidence Summary Gestational Diabetes Mellitus, Screening May 15, 2013 Recommendations made by the USPSTF are independent of the U.S. government. Th…

46. Final Research Plan: Gestational Diabetes: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/gestational-diabetes-screening
    June 06, 2019 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Final Research Plan Gestational Diabetes: Screening June 06, 2019 Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed a…

47. Final Research Plan: Prediabetes and Type 2 Diabetes: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/screening-for-prediabetes-and-type-2-diabetes
    November 15, 2018 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Final Research Plan Prediabetes and Type 2 Diabetes: Screening November 15, 2018 Recommendations made by the USPSTF are independent of the U.S. government. They should not be …

48. Archived: Gestational Diabetes Mellitus, Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/gestational-diabetes-mellitus-screening-january-2014
    January 14, 2014 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Final Recommendation Statement Gestational Diabetes Mellitus, Screening January 14, 2014 Recommendations made by the USPSTF are independent of the U.S. governm…

49. Archived: Final Research Plan: Abnormal Blood Glucose and Type 2 Diabetes Mellitus: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan16/screening-for-abnormal-blood-glucose-and-type-2-diabetes-october-2015
    August 15, 2013 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Final Research Plan Abnormal Blood Glucose and Type 2 Diabetes Mellitus: Screening August 15, 2013 Recommendations made by the USPSTF are independent of the U.S. …

50. Clinician Summary of USPSTF Recommendation: Prediabetes and Type 2 Diabetes (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/HFVpc3j6HjLDkFxfqrr4wG
    August 01, 2021 - Clinician Summary of USPSTF Recommendation: Prediabetes and Type 2 Diabetes 1 www.uspreventiveservicestaskforce.org Clinician Summary of USPSTF Recommendation Prediabetes and Type 2 Diabetes August 2021 The USPSTF recognizes that clinical decisions involve more considerations than evidence alone. Clinicians…

51. Final Research Plan: Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/obesity-in-adults-interventions
    March 31, 2016 - pharmacologic interventions Outcomes KQ 1: Health outcomes: Mortality Morbidity (e.g., diabetic

52. Screening for Gestational Diabetes Mellitus: Clinical Summary of USPSTF Recommendation (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/zuBMgkDP5VuWPPQCpfcSey
    Screening for Gestational Diabetes Mellitus: Clinical Summary of USPSTF Recommendation SCREENING FOR GESTATIONAL DIABETES MELLITUS CLINICAL SUMMARY OF U.S. PREVENTIVE SERVICES TASK FORCE RECOMMENDATION Population Asymptomatic pregnant women after 24 weeks of gestation Asymptomatic pregnant women before 24 we…

53. 4Z Bygyyfkv5Uru6Fjx8Pb (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/4z_ByGyYfKV5uRU6fjx8pB
    March 01, 2014 - Screening for Gestational Diabetes Mellitus: U.S. Preventive Services Task Force Recommendation Statement Virginia A. Moyer, MD, MPH, on behalf of the U.S. Preventive Services Task Force* Description: Update of the 2008 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for gestational dia- betes…

54. Archived: Treatment: Evidence Summary: Gestational Diabetes Mellitus, Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/treatment-evidence-summary/gestational-diabetes-mellitus-screening-january-2014
    May 28, 2013 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Treatment: Evidence Summary Gestational Diabetes Mellitus, Screening May 28, 2013 Recommendations made by the USPSTF are independent of the U.S. government. Th…

55. Archived: Final Evidence Summary: Obesity in Adults: Screening and Management | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary38/obesity-in-adults-screening-and-management-2012
    October 15, 2011 - interventions, orlistat, and metformin all led to declines in fasting glucose levels in prediabetic and diabetic … 0.672 mmol/L [12.1 mg/dL]) greater than placebo]], possibly because those studies were conducted in diabetic … interventions (considered comparative effectiveness), including Look AHEAD, a weight-loss intervention trial in diabetic … Comparison of orlistat treatment and placebo in obese type 2 diabetic patients.

56. Q Nxyq7Cwpbuwvt27Sq42 (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/Q__nXYQ7cWPBuwvt27sQ42
    July 01, 2013 - Screening Tests for Gestational Diabetes: A Systematic Review for the U.S. Preventive Services Task Force Lois Donovan, MD; Lisa Hartling, PhD; Melanie Muise, MA; Alyssa Guthrie, MSSc; Ben Vandermeer, MSc; and Donna M. Dryden, PhD Background: A 50-g oral glucose challenge test (OGCT) is a widely accepted screening met…

57. Evidence Summary: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/statin-use-in-adults-preventive-medication
    August 23, 2022 - targeted to LDL-C less than 70 mg/dL vs 100 to 120 mg/dL on cardiovascular outcomes in patients with diabetic … Intensive treat-to-target statin therapy in high-risk Japanese patients with hypercholesterolemia and diabetic

58. Screening for Gestational Diabetes Mellitus: Clinical Summary of U.S. Preventive Task Force Recommendation (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/6WFgDkD6kVsynLyYYMPVKk
    Screening for Gestational Diabetes Mellitus: Clinical Summary of U.S. Preventive Task Force Recommendation Screening for Gestational Diabetes Mellitus: Clinical Summary of U.S. Preventive Task Force Recommendation Population Pregnant Women Who Have Not Previously Been Diagnosed With Diabetes Re…

59. Screening for Gestational Diabetes: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/TYPA75a_t7HaJeDhWqCJ9n
    August 13, 2019 - Screening for Gestational Diabetes: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force Screening for Gestational Diabetes Updated Evidence Report and Systematic Review for the US Preventive Services Task Force Jennifer Pillay, MSc; Lois Donovan, MD; Samantha Guitard, MSc; Bernadet…

60. Effectiveness of Primary Care–Relevant Treatments for Obesity in Adults: A Systematic Evidence Review for the USPSTF (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/hbSopN6uA9u-4EQuKtRGDP
    October 01, 2011 - interventions, orlistat, and met- formin all led to declines in fasting glucose levels in prediabetic and diabetic … (0.672 mmol/L [12.1 mg/dL] greater than placebo), possibly because those studies were conducted in diabetic … interventions (considered comparative effectiveness), including Look AHEAD, a weight-loss intervention trial in diabetic … Comparison of orlistat treatment and placebo in obese type 2 diabetic patients.